EVALUATION OF APPETITE SUPPRESSANTS
Authors: L J CASS
Journal: Annals of Internal Medicine (1959)

Article1 December 1959EVALUATION OF APPETITE SUPPRESSANTSLEO J. CASS, M.D.LEO J. CASS, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-51-6-1295 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe high incidence of obesity in our population presents a definite public health problem. It is estimated that approximately 20 million people in the United States are clinically obese, and that 5 million of these weigh at least 20% above the optimum. The magnitude of the problem is presented in the insurance statistics, which clearly define the increased mortality rates for overweight individuals, especially those beyond the age of 45. Obesity is associated with increased susceptibility to cardiovascular disease, diabetes and gall-bladder disease, and of course represents an additional risk in surgery.1Although there are recognized hereditary, constitutional and hormonal...Bibliography1. ArmstrongDublinWheatleyMarks DBLIGMHH: Obesity and its relation to health and disease, J. A. M. A. 147: 1007-1014, 1951. CrossrefMedlineGoogle Scholar2. WilliamsDaughadayRogersAsperTowery RHWHWFSPBT: Obesity and its treatment, with particular reference to the use of anorexigenic compounds, Ann. Int. Med. 29: 510-532, 1948. LinkGoogle Scholar3. AdlersbergMager DME: Results of prolonged medical treatment of obesity with diet alone, diet and thyroid preparations, and diet and amphetamine, J. Clin. Endocrinol. 9: 275-284, 1949. CrossrefGoogle Scholar4. OssermannDolger KEH: Obesity in diabetes: a study of therapy with anorexigenic drugs, Ann. Int. Med. 34: 72-79, 1951. LinkGoogle Scholar5. Freed SC: Newer concepts in treating obesity, GP 7: 63, 1953. MedlineGoogle Scholar6. FreedKeatingHays SCJWEE: Amphetamine-resin complex for prolonged appetite suppression, Ann. Int. Med. 44: 1136-1141 (June) 1956. LinkGoogle Scholar7. Robillard R: Preludin, Canad M. A. J. 76: 938, 1947. Google Scholar8. GadekFeldmanLivingstonLucariello RJHSNJRJ: Study of 1-phenyl-2-amino-propanealginate, new anorectic, J. A. M. A. 167: 433-436, 1958. CrossrefMedlineGoogle Scholar9. Ressler C: Treatment of obesity with phenmetrazine hydrochloride, J. A. M. A. 165: 135-137, 1957. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Cambridge, Massachusetts*Received for publication March 23, 1959.From the Harvard University Law School Health Services, Cambridge, Massachusetts.Requests for reprints should be addressed to Leo J. Cass, M.D., University Health Services, Harvard Law School, Austin Hall, Cambridge 38, Massachusetts. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byANOREXIGENIC DRUGS IN PERSPECTIVEObesity in childhood. A controlled trial of anorectic drugs.Suicidversuch mit PhenterminA Comparison of the Appetite Suppressing Properties of Dexamphetamine and PhenterminePharmacologic activity of phentermine (Phenyl-t-butylamine) 1 December 1959Volume 51, Issue 6Page: 1295-1302KeywordsCardiovascular disease riskCardiovascular diseasesDeath ratesGenetic diseasesMedical servicesObesityOverweightPrevention, policy, and public health ePublished: 1 December 2008 Issue Published: 1 December 1959 PDF downloadLoading ...